VA
Valmark Advisers’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $387K | Buy |
5,603
+40
| +0.7% | +$2.76K | 0.01% | 486 |
|
|
2025
Q1 | $386K | Sell |
5,563
-1,064
| -16% | -$73.9K | 0.01% | 466 |
|
|
2024
Q4 | $570K | Buy |
6,627
+136
| +2% | +$11.7K | 0.01% | 395 |
|
|
2024
Q3 | $773K | Sell |
6,491
-675
| -9% | -$80.4K | 0.01% | 348 |
|
|
2024
Q2 | $1.02M | Buy |
7,166
+1,441
| +25% | +$206K | 0.02% | 278 |
|
|
2024
Q1 | $735K | Buy |
5,725
+468
| +9% | +$60.1K | 0.01% | 317 |
|
|
2023
Q4 | $544K | Buy |
5,257
+2,375
| +82% | +$246K | 0.01% | 338 |
|
|
2023
Q3 | $262K | Buy |
2,882
+1,599
| +125% | +$145K | 0.01% | 413 |
|
|
2023
Q2 | $208K | Sell |
1,283
-132
| -9% | -$21.4K | ﹤0.01% | 458 |
|
|
2023
Q1 | $225K | Buy |
+1,415
| New | +$225K | ﹤0.01% | 438 |
|